Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Plasma cell dyscrasias.

D H Buss1, R W Prichard, M R Cooper

  • 1Wake Forest University, Bowman Gray School of Medicine, Winston-Salem, North Carolina.

Hematology/Oncology Clinics of North America
|December 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Preclinical activity of CPI-0610, a novel small-molecule bromodomain and extra-terminal protein inhibitor in the therapy of multiple myeloma.

Leukemia·2016
Same author

Phase III study of cyclophosphamide, doxorubicin, and fluorouracil (CAF) plus leucovorin versus CAF for metastatic breast cancer: Cancer and Leukemia Group B 9140.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2003
Same author

Fatal EBV-related post-transplant lymphoproliferative disorder (LPD) after matched related donor nonmyeloablative peripheral blood progenitor cell transplant.

Bone marrow transplantation·2003
Same author

Alemtuzumab in previously treated chronic lymphocytic leukemia patients who also had received fludarabine.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2002
Same author

Cancer control and the Central Cancer Registry of North Carolina.

North Carolina medical journal·2001
Same author

Cyclophosphamide, doxorubicin, vincristine, prednisone, and etoposide (CHOPE) for advanced-stage Hodgkin's disease: CALGB 8856.

Cancer investigation·2001
Same journal

Palliative Therapy for Liver and Biliary Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Ablative Therapies for Liver Tumors.

Hematology/oncology clinics of North America·2026
Same journal

Pathology of Liver and Biliary Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Minimally Invasive Surgery for Liver and Biliary Tract Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Surgical Considerations for Primary Liver Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Systemic Therapy for Biliary and Liver Neoplasms: Chemotherapy and Immunotherapy.

Hematology/oncology clinics of North America·2026
See all related articles

Bone marrow examination is useful but challenging for diagnosing plasma cell dyscrasias due to overlapping features and sampling issues. Immunohistochemistry and clinical correlation are crucial for accurate interpretation.

Area of Science:

  • Hematology
  • Oncology
  • Pathology

Background:

  • Plasma cell dyscrasias present overlapping clinical and morphologic features.
  • Accurate diagnosis is essential for appropriate patient management.
  • Bone marrow examination is a key diagnostic tool.

Purpose of the Study:

  • To evaluate the utility and limitations of bone marrow examination in diagnosing plasma cell dyscrasias.
  • To highlight challenges in bone marrow interpretation.
  • To emphasize the role of ancillary techniques and clinical correlation.

Main Methods:

  • Review of bone marrow examination findings in plasma cell dyscrasias.
  • Discussion of diagnostic challenges including overlapping features and sampling variability.

Related Experiment Videos

  • Evaluation of immunohistochemistry applications.

    • Main Results:

    • Bone marrow examination provides valuable diagnostic information but faces limitations.
    • Overlapping features and random sampling can lead to interpretation difficulties.
    • Immunohistochemistry enhances diagnostic accuracy.

    Conclusions:

    • Bone marrow examination is indispensable for diagnosing plasma cell dyscrasias.
    • Careful interpretation integrating morphology, immunohistochemistry, and clinical data is vital.
    • Addressing sampling variability and overlapping features improves diagnostic outcomes.